New York State Common Retirement Fund increased its position in Soliton, Inc. (NASDAQ:SOLY) by 497.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,958 shares of the company’s stock after buying an additional 7,458 shares during the quarter. New York State Common Retirement Fund’s holdings in Soliton were worth $201,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently made changes to their positions in SOLY. Covington Capital Management purchased a new stake in Soliton in the first quarter worth $91,000. UBS Group AG increased its position in Soliton by 87.1% during the first quarter. UBS Group AG now owns 6,264 shares of the company’s stock valued at $110,000 after acquiring an additional 2,916 shares during the last quarter. California State Teachers Retirement System increased its position in Soliton by 11.2% during the first quarter. California State Teachers Retirement System now owns 11,059 shares of the company’s stock valued at $194,000 after acquiring an additional 1,110 shares during the last quarter. Harbor Financial Services LLC purchased a new stake in Soliton in the first quarter worth about $198,000. Finally, Grimes & Company Inc. purchased a new stake in shares of Soliton during the first quarter worth about $257,000. 34.81% of the stock is currently owned by institutional investors and hedge funds.
Several equities research analysts have recently issued reports on SOLY shares. Zacks Investment Research raised Soliton from a “sell” rating to a “hold” rating in a research note on Wednesday, August 4th. Roth Capital lowered Soliton from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 2nd.
Soliton (NASDAQ:SOLY) last released its quarterly earnings data on Thursday, August 12th. The company reported ($0.37) EPS for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.07). Analysts anticipate that Soliton, Inc. will post -1.21 earnings per share for the current year.
Soliton, Inc is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue.
Further Reading: Average Daily Trade Volume Explained
Receive News & Ratings for Soliton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soliton and related companies with MarketBeat.com's FREE daily email newsletter.